Effects of Zofenopril on Arterial Stiffness in Hypertension Patients
Benjamin Palić,
No information about this author
Ivica Brizić,
No information about this author
Emina Karahmet Sher
No information about this author
et al.
Molecular Biotechnology,
Journal Year:
2023,
Volume and Issue:
unknown
Published: Sept. 13, 2023
Abstract
Angiotensin-converting
enzyme
inhibitors
(ACEIs)
reduce
arterial
stiffness
beyond
their
antihypertensive
effect.
Studies
showed
that
sulfhydryl
ACEIs
have
the
antioxidative
potential
to
improve
endothelial
function,
which
might
a
clinical
effect
on
distensibility.
However,
there
are
no
studies
directly
compare
effects
of
(zofenopril)
and
non-sulfhydryl
(enalapril)
stiffness.
Therefore,
this
prospective
study
aims
enalapril
zofenopril
oxidative
stress
in
both
short-
long-term
treatment
hypertension
(AH).
Baseline
post-treatment
peripheral
central
pressure
indices,
augmentation
index
(Aix),
aortic
pulse
wave
velocity
(ao-PWV),
serum
levels
oxidized
low-density
cholesterol
lipoprotein,
LDL
uric
acid
(UA)
were
measured.
The
results
acute
with
zofenopril,
contrast
enalapril,
significantly
decreased
Aix
(p
<
0.001).
Chronic
superior
over
reduction
systolic
ao-PWV
=
0.004),
as
well
0.021)
0.021).
indicates
has
beneficial
compared
enalapril.
It
potent
efficacy
AH
further
should
its
safety
other
drugs
would
aid
clinicians
treating
various
cardiovascular
diseases
common
denominator.
Language: Английский
Association of visceral fat area or BMI with arterial stiffness in ideal cardiovascular health metrics among T2DM patients
Ling Zhao,
No information about this author
Xiangming Zhou,
No information about this author
Yufei Chen
No information about this author
et al.
Journal of Diabetes,
Journal Year:
2023,
Volume and Issue:
16(1)
Published: Sept. 8, 2023
Abstract
Background
“Obesity
paradox”
occurs
in
type
2
diabetes
mellitus
(T2DM)
patients
when
body
mass
index
(BMI)
is
applied
to
define
obesity.
We
examined
the
association
of
visceral
fat
area
(VFA)
as
an
obesity
measurement
with
arterial
stiffness
seven
ideal
cardiovascular
health
metrics
(ICVHMs).
Methods
A
total
29
048
were
included
analysis
from
June
2017
April
2021
10
sites
National
Metabolic
Management
Centers.
ICVHMs
modified
recommendations
American
Heart
Association.
Brachial‐ankle
pulse
wave
velocity
(BaPWV)
≥
1400
cm/s
was
employed
evaluate
increased
stiffness.
Multivariate
regression
models
used
compare
different
effects
BMI
and
VFA
on
Results
Lower
more
strongly
associated
low
BaPWV
than
lower
other
(adjusted
odds
ratio
[OR],
0.85
[95%
confidence
interval
[CI],
0.80–0.90]
vs
OR
1.08
CI,
1.00–1.17]).
Multivariable‐adjusted
ORs
for
highest
VAT
range
150‐200
cm
OR,
1.26
CI
1.12–1.41]).
Compared
participants
<
100
,
among
higher
VFA,
decreased
gradually
1.89
(95%
1.73–2.07)
who
had
≤1
ICVHM
0.39
0.25–0.62)
≥5
ICVHMs.
Conclusion
In
T2DM,
using
anthropometric
measures
obesity,
relevant
risk
For
describe
would
be
optimal
BMI.
Language: Английский
Clinically relevant plasma proteome for adiposity depots: evidence from systematic mendelian randomization and colocalization analyses
Min Cao,
No information about this author
Bin Cui
No information about this author
Cardiovascular Diabetology,
Journal Year:
2024,
Volume and Issue:
23(1)
Published: April 13, 2024
Abstract
Background
The
accumulation
of
visceral
and
ectopic
fat
comprise
a
major
cause
cardiometabolic
diseases.
However,
novel
drug
targets
for
reducing
unnecessary
are
still
limited.
Our
study
aims
to
provide
comprehensive
investigation
the
causal
effects
plasma
proteome
on
using
Mendelian
randomization
(MR)
approach.
Methods
We
performed
two-sample
MR
analyses
based
five
large
genome-wide
association
(GWAS)
summary
statistics
2656
proteins,
screen
associations
these
proteins
with
traits
in
over
30,000
participants
European
ancestry,
as
well
assess
mediation
by
risk
factors
outcomes.
colocalization
analysis
was
conducted
examine
whether
identified
outcomes
shared
casual
variants.
Results
Genetically
predicted
levels
14
circulating
were
associated
(
P
<
4.99
×
10
−
5
,
at
Bonferroni-corrected
threshold).
Colocalization
prioritized
ten
protein
that
showed
effect
outcomes,
including
FST,
SIRT2,
DNAJB9,
IL6R,
CTSA,
RGMB,
PNLIPRP1,
FLT4,
PPY
IL6ST.
revealed
seven
0.0024).
Furthermore,
DNAJB9
IGFBP1
primary
mediated
HDL-C
SHBG.
Sensitivity
little
evidence
pleiotropy.
Conclusions
candidate
showing
putative
potential
therapeutic
outlined
pathways
further
prevention
downstream
Language: Английский